Why Fabrinet Stock Just Plummeted

Fabrinet shares fell 19.4% after reporting fiscal Q4 2026 results that beat expectations but came with free-cash-flow pressure. Adjusted EPS was $4.10 on sales of $1.32B (up ~45% YoY), ahead of consensus, while guidance called for adjusted EPS of $4.10–$4.25 on revenue of $1.375B–$1.425B versus roughly $3.99 EPS and ~$1.32B sales expected. However, free cash flow swung to -$36.9M in the quarter from high capex, pulling full-year FCF to about $4M, raising investor concerns about infrastructure spending.

Analysis

The market is not punishing the growth print; it is repricing the quality of that growth. In hardware supply chains, a strong top line can still be value-destructive if every incremental dollar requires another round of capacity build-out, because equity holders end up financing working capital and capex before seeing any durable free-cash-flow conversion. That makes FN vulnerable to a lower multiple even if demand remains healthy, while capital-efficient peers such as JBL and CLS should look comparatively better on EV/sales-to-FCF conversion.

Near term, this is a de-rating event, not a fundamentals collapse. Over the next 1-3 months the key catalyst is whether management shows capex peaking and FCF turning back positive; if not, the street will start treating the model as structurally low-cash-yield and reduce its willingness to pay for growth. The tail risk is that the company keeps adding capacity ahead of orders and margins do not expand enough to absorb the fixed-cost base, which would compress the multiple further even if revenue keeps compounding.

The contrarian view is that the selloff may be overdone if this is a deliberate, front-loaded investment cycle tied to AI/optical demand and not a demand miss. If that is the case, the right way to play it is not to fade the company’s revenue trajectory, but to wait for proof that capex intensity is normalizing. What would falsify the bearish case is a subsequent quarter showing positive FCF inflection with steady gross margin improvement; absent that, this is a cash conversion story, not a growth story.

Key Decisions for Investors

• Short FN on any reflex bounce over the next 1-3 weeks; thesis is multiple compression from negative FCF, with risk limited if management pre-announces capex normalization.
• Pair trade: long JBL / short FN for 1-3 months to isolate cash-conversion quality versus capex-heavy growth; best if the market keeps rewarding free-cash-flow discipline.
• Alternative relative-value: long CLS / short FN into the next earnings cycle if you want AI-infrastructure exposure with better perceived balance between growth and cash generation.
• Buy a 1-3 month FN put spread instead of outright short stock if you want event-driven downside with defined risk; thesis breaks if next update shows capex peaking and FCF turning positive.
• Watch item: if FN reports another quarter of negative FCF despite continued revenue beats, stay underweight for 6-18 months; if FCF turns positive, cover shorts and reassess the reset as a temporary investment cycle.